Brief: Aptose Biosciences Says On Nov 18, Co Notified Piper Sandler, Canaccord Genuity To Terminate An Equity Distribution Agreement Dated May 5, 2020
25/11/2022 21:47
Nov 25 (Reuters) - Aptose Biosciences Inc APS.TO :
* APTOSE BIOSCIENCES - ON NOV 18, CO NOTIFIED PIPER SANDLER
&
CANACCORD GENUITY TO TERMINATE AN EQUITY DISTRIBUTION AGREEMENT
DATED MAY 5, 2020
Further company coverage: APS.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aptose Biosciences
See all newsBrief: Aptose Biosciences Says Closing Of Arrangement With Hanmi Pharmaceutical Further Delayed
Brief: Aptose Reports First Quarter 2026 Results
Brief: Leading Independent Proxy Advisory Firm Glass Lewis Endorses Aptose Plan Of Arrangement
Brief: Leading Independent Proxy Advisory Firm Iss Recommends Aptose Biosciences Shareholders Vote “For” Proposed Plan Of Arrangement With Hanmi Pharmaceutical
Brief: Aptose Biosciences Announces Amendment To Arrangement Agreement And Details Of Shareholders Meeting